Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell for Rheumatoid Arthritis
NCT05003934Phase 1Recruiting
- Sponsor
- The Foundation for Orthopaedics and Regenerative Medicine
- Start
- Nov 2021
- Primary completion
- Sep 2028
- Modality
- Stem Cell Therapies
- Countries
- 2
01
Overview
Phase 1, open-label, single-arm trial in rheumatoid arthritis (RA), sponsored by The Foundation for Orthopaedics and Regenerative Medicine. Primary endpoint: Adverse Events at 4 years. Started Nov 2021; status: recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05003934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05003934.